-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

508.P1.27 508. Bone Marrow Failure: Poster I

Program: Oral and Poster Abstracts
Type: Poster
Hematology Disease Topics & Pathways:
Adult, AML, Anemias, Biological, HSCs, aplastic anemia, bone marrow, Diseases, Non-Biological, Bone Marrow Failure, Diamond Blackfan Anemia, platelets, Therapies, Genetic Disorders, Pediatric, Biological Processes, DNA damage, white blood cells, cell expansion, PNH, Technology and Procedures, Young Adult, Cell Lineage, epigenetics, Study Population, Clinically relevant, genomics, Myeloid Malignancies, hematopoiesis, flow cytometry, immune mechanism, transplantation, stem cells, RNA sequencing, pathogenesis, pathways
Saturday, December 5, 2020: 7:00 AM-3:30 PM

Anne Olazabal-Herrero, PhD1,2*, Allison M. Green3*, Xiaoyong Chen4*, Patrick Sung, PhD5*, Manoj M Pillai, MD6 and Gary M. Kupfer, MD7

1Department of Oncology, Georgetown University, Washington, DC
2Department of Internal Medicine, Yale University School of Medicine, New Haven, CT
3Department of Pediatrics, Yale University School of Medicine, New Haven, CT
4Yale, New Haven, CT
5University of Texas Health Sciences Center San Antonio, San Antonio
6Department of Internal Medicine, Section of Hematology, Yale University School of Medicine, New Haven, CT
7Department of Oncology, Georgetown University, washington, DC

Marena R. Niewisch, MD1*, Neelam Giri, MD2, Lisa J. McReynolds, MD, PhD3, Sonia Bhala, BS4*, Rotana Alsaggaf, PhD, MS1*, Blanche P. Alter, MD, MPH1 and Sharon A. Savage, MD1

1Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD
2Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD
3NCI, National Institutes of Health, Bethesda, MD
4Rutgers Robert Wood Johnson Medical School, Piscataway, NJ

Simona Pagliuca, MD1,2, Carmelo Gurnari, MD1,3*, Hassan Awada, MD1, Cassandra M Kerr, MS1*, Bhumika J. Patel, MD4, Laila Terkawi1*, Misam Zawit, MBBS1*, Sunisa Kongkiatkamon, MD1*, Pedro H Prata, MD5, Ashwin Kishtagari, MBBS1, Adam Wahida6*, Thomas Laframboise, PhD7*, Valeria Visconte, PhD1, Regis Peffault De Latour, MD, PhD5,8* and Jaroslaw P. Maciejewski, MD, PhD9

1Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH
2Université de Paris, Paris, France
3Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy
4Leukemia Program, Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH
5Department of Hematology and Transplantation, Hôpital Saint Louis, Paris, France
6MLL Munich Leukemia Laboratory, Munich, Germany
7Genetics and Genome Sciences Department, Case Western Reserve University, Cleveland, OH
8French Reference Center for Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria, Assistance Publique – Hôpitaux de Paris, Université de Paris, Paris, France
9Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH

Carmelo Gurnari, MD1,2*, Simona Pagliuca, MD2,3, Cassandra M Kerr, MS2*, Hassan Awada, MD2, Sunisa Kongkiatkamon, MD2*, Laila Terkawi2*, Neetha Parameswaran, PhD2, Misam Zawit, MBBS2*, Adam Wahida4*, Valeria Visconte, PhD2 and Jaroslaw P. Maciejewski, MD, PhD5

1Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy
2Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH
3Université de Paris, Paris, France
4MLL Munich Leukemia Laboratory, Munich, Germany
5Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH

Jean-Alain Martignoles1*, Pierre Hirsch, MD, PhD2*, Blandine Beaupain3*, Thomas Longval, MD4*, Nawa Hachem, MsC5*, Mira El-Khoury, PhD6*, Sophie Kaltenbach7*, Jean Soulier, MD, PhD8, Thierry Leblanc, M.D.9,10*, Pierre Simon Rohrlich, MD PhD11*, Eric Jeziorski, MD PhD12*, Isabelle Meyts13*, Dalila Adjaoud, MD14*, Vincent Barlogis, M.D., Ph.D.15*, Marlène Pasquet, M.D., Ph.D.16*, Laetitia Largeaud17*, Flore Sicre de Fontbrune18*, Claire Fieschi, MD, PhD19*, Virginie Gandemer, MD, PhD20*, Nathalie Aladjidi, MD21*, Fanny Fouyssac, MD22*, Guy Leverger, M.D.23*, Wadih Abou Chahla, M.D.24*, Stephane Blanche, MD25*, Despina Moushous, MD, PhD26*, Aline Moignet Autrel, MD27*, Yves Bertrand, M.D.28,29*, Cecile Renard29,30*, Pascale Flandrin-Gresta, MD31,32*, Jean Louis Stephan, MD PhD33*, Olivier Tournilhac, MD, PhD34,35*, Liana Carausu36*, Frederic Millot, M.D.37*, Marielaure Couec, MD38*, Claude Preudhomme, MD, PhD39,40,41,42, Hélène Lapillonne, MD, PhD43*, Vahid Asnafi, MD, PhD44,45,46*, Patrick Revy47*, Christine Bellanne-Chantelot, PhD, PharmD48,49*, Francois Delhommeau, MD, PhD2,50* and Jean Donadieu, MD, PhD51

1Sorbonne Université, UMRS 938 "hematopoietic and Leukemic Development", A, Paris, FRA
2APHP, Hôpital Saint Antoine, Service d'hématologie Biologique, Paris, France
3Registre francais des neutropénies chroniques, HôPital Trousseau, France, FRA
4APHP hopital saint antoine, Laboratoire hématologie, Paris, France
5laboratoire d’hématologie Saint-Antoine, Sorbonne Université CRSA UMRS938, paris, France
6Gustave Roussy, INSERM, UMR1170, Villejuif, France
7INSERM U768, Paris, FRA
8Hematology Laboratory and INSERM U944, Hopital Saint-Louis Centre Hayem 2ETG, Paris, France
9Pediatric Hematology Unit, Robert-Debré Hospital, AP-HP, Paris, France
10French Reference Center for Aplastic Anemia, Paris, France
11CHU L'Archet, Nice, FRA
12Pediatrics, CHU Montpellier, Montpeller, FRA
13UZ Leuven, Leuven, BEL
14hemato oncologie pédiatrique, CHU de Grenoble, Grenoble, France
15Department of Pediatric Hematology, La Timone Hospital, AP-HM, Marseille, France
16Pediatric Oncology Immunology Hematology Unit, Children’s hospital, CHU de Toulouse, Toulouse, France
17Institut Universitaire Du Cancer De Toulouse-Oncopole, Toulouse, FRA
18Centre de Référence Aplasie Médullaire, Service d’Hématologie Greffe, Assistance Publique des Hôpitaux de Paris, Hôpital Saint-Louis, Paris, France
19Service d’Immunologie clinique, Hôpital Saint-Louis, AP-HP, Paris, France
20CHU Hopital Sud, Rennes, FRA
2112. Unité d’Hématologie Pédiatrique, CIC 1401 INSERM CICP, CHU Bordeaux, Bordeaux, France
22hemato oncologie pédiatrique, CHU de Nancy, Nancy, France
23Pediatric Hematology Oncology Immunology Department, Armand-Trousseau University Hospital, AP-HP, Paris, France
24Department of Pediatric Hematology, Jeanne de Flandre Hospital, CHRU de Lille, Lille, France
25Department of Pediatric Immunology, Hematology and Rheumatology, Necker Enfants Malades University Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France
26Unité d'immuno hématologie rhumatologie pédiatrique, APHP université de Paris Hopital Necker enfants malades, Paris, France
27Clinical Hematology Department, Rennes CHU, Rennes, France
28Institute of Pediatric Hematology and Oncology, Civil Hospital of Lyon, Claude Bernard University, Lyon, France
29Claude Bernard University, Lyon 1, Lyon, France
30IHOPE, Civil Hospital of Lyon, Lyon, France
31Hopital Saint Antoine, Laboratoire d'Hématologie, AP-HP Hôpital Saint Antoine, Sorbonne Universités, UPMC Univ Paris 06, UMR_S 938, CDR Saint-Antoine,, paris, France
32Laboratoire d'Hématologie, CHU de Saint-Etienne, Saint-Priest-en-Jarez, France
33Pediatric Hemato-Oncology, CHU de Saint Etienne , Hôpital Nord, Saint-priest-en-Jarez, FRA
34Service d'Hématologie Clinique et Thérapie Cellulaire, CHU, Université Clermont Auvergne EA7453 Chelter CIC-1405, Clermont-Ferrand, FRA
35Hématologie Clinique Adulte et Thérapie Cellulaire, CHU Hotel Dieu Hématologie, Clermont-Ferrand, France
36CHRU Brest, Brest, FRA
37Department of Pediatric Hematology-Oncology, University Hospital Poitiers, Poitiers, France
38hemato oncologie Pédiatrique, CHU Nantes, nantes, France
39Institut de Recherche contre le Cancer de Lille, UMR-S1172, Lille, France
40Centre de Biologie-Pathologie, CHU Lille, Lille, France
41UMR-S 1172, INSERM, Lille, France
42Cancer Research Institute, INSERM Unité Mixte de Recherche (UMR)-S 1172, F-59000 Lille, CHU Lille, Laboratory of Hematology, F-59000 Lille, Lille, France
43Pediatric Hematology and Oncology Department, Hôpital Armand Trousseau, Paris, France
44INSERM U1151, Université Paris Descartes Sorbonne Cité, Paris, France
45Laboratory of Onco-Hematology, Hôpital Necker Enfants-Malades, APHP, Paris, France
46Biological Hematology, Necker University Hospital, Paris, France
47Institut Imagine, Paris, FRA
48Hopital Pitié Salpétriére APHP, Département de Génétique, AP-HP Hôpital Pitié- Salpêtrière, UPMC Univ Paris 06, Paris, France
49Département de Neurologie, Hôpital Pitié-Salpêtrière, Paris, France
50INSERM U938, Paris, France
51Service d'Hémato-Oncologie Pédiatrique, Hopital Trousseau, Paris, Cedex, France

Bruno Quintino Oliveira, brunoqolvr@gmail.com1*, Bárbara Santana, PhD1*, Luiz Fernando Bazzo Catto, MD, PhD1*, Maria Florencia Tellechea, PhD1*, Priscila Santos Scheucher, PhD1*, Phillip Scheinberg, MD2 and Rodrigo T. Calado, MD, PhD1

1Department of Medical Imaging, Hematology, and Clinical Oncology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil
2Division of Hematology, Hospital A Beneficência Portuguesa, Sao Paulo, Brazil

Noriaki Tsuji, MD1*, Kohei Hosokawa, MD, PhD 1, Ryota Urushihara, MD1*, Mikoto Tanabe, MD1*, Hiroyuki Takamatsu, MD, PhD1, Ken Ishiyama, MD, PhD1, Hirohito Yamazaki, MD, PhD2* and Shinji Nakao, MD, PhD1

1Department of Hematology, Kanazawa University, Kanazawa, Japan
2Division of Transfusion Medicine, Kanazawa University Hospital, Kanazawa, Japan

Hillard Lazarus1*, Carolina Escobar, MD2*, Leland Metheny III, MD1,3, Joseph P. McGuirk, DO4,5, Tsila Zuckerman, MD6,7, Mark Litzow, MD8, Scott D. Rowley, MD9, Racheli Ofir, PhD10*, Liran Shani, MD11* and Jacob M. Rowe, MB, BS12

1Case Western Reserve University, Cleveland, OH
2Texas Oncology-Baylor Charles A. Sammons Cancer Center Blood and Marrow Transplant, Dallas, TX
3Adult Hematologic Malignancies & Stem Cell Transplant Section, University Hospitals Seidman Cancer Center, Cleveland, OH
4The University of Kansas Cancer Center, Westwood, KS
5Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS
6Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel
7The Ruth and Bruce Rappaport Faculty of Medicine, Technion – Israel Institute of Technology, Haifa, Israel
8Division of Hematology, Mayo Clinic, Rochester, MN
9John Theurer Cancer Center, Myeloma and Lymphoma Divisions, NNJCA, Hackensack, NJ
10Pluristem LTD, HAIFA, Israel
11Pluristem ltd, HAIFA, Israel
12The Ruth and Bruce Rappaport Faculty of Medicine, Shaare Zedek Medical Center, Jerusalem, Israel

Michelle Nash, MD1*, Adrianna Vlachos, MD2, Marcin W. Wlodarski, MD, PhD3 and Jeffrey M Lipton, MD, PhD4

1Cohen Children's Medical Center, Commack, NY
2Feinstein Institute of Medical Research, Cohen Children's Medical Center, Manhasset, NY
3St. Jude Children's Research Hospital, Memphis, IN
4Hematology/Oncology and Stem Cell Transplantation, Cohen Children's Medical Center of NY, New Hyde Park, NY

Yeon Jung Lim, MD1,2*, Omri Avraham Arbiv3*, Melanie Evelyn Kalbfleisch4*, Mohammed Al Nuaimi, MD5*, MacGregor Steele, MD, FRCPC6, Geoff D.E. Cuvelier, MD7, Tal Schechter-Finkelstein, MD8, Bozana Zlateska, MD, MSc9*, Michaela Cada, MD, FRCPC, FAAP, MPH10 and Yigal Dror, MD, FRCPC10

1Program in Genetics and Genome Biology, Research Institute, Hospital for Sick Children, Toronto, Canada
2Department of Pediatrics, College of Medicine, Chungnam National University, Daejeon, Korea, Republic of (South)
3Marrow Failure and Myelodysplasia Program, Division of Haematology/Oncology, Genetics and Genome Biology Program, Research Institute, The Hospital for Sick Children and the University of Toronto, Toronto, ON, Canada
4Marrow Failure and Myelodysplasia Program, Division of Haematology/Oncology, Department of Paediatrics, Genetics and Genome Biology Program, The Hospital for Sick Children and the University of Toronto, Toronto, ON, Canada
5Marrow Failure and Myelodysplasia Program, Division of Haematology/Oncology, Department of Paediatrics, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada
6Cumming School of Medicine, Alberta Children's Hospital, University of Calgary, Calgary, AB, Canada
7Pediatric Blood and Marrow Transplant, Manitoba Blood and Marrow Transplant Program, CancerCare Manitoba, University of Manitoba, Winnipeg, MB, Canada
8The Hospital for Sick Children, Toronto, Canada
9Department of Genetics and Genome Biology, The Hospital for Sick Children, Toronto, ON, Canada
10Marrow Failure and Myelodysplasia Program, Division of Hematology/Oncology, Department of Pediatrics, Hospital for Sick Children, Toronto, ON, Canada

Rong Fu, PhD1,2*, Yang Li1*, Zhaoyun Liu3*, Chunyan Liu4*, Hui Liu2* and Zonghong Shao, PhD2

1Tianjin Medical University General Hospital, Tianjin, China
2Department of Hematology, Tianjin Medical University General Hospital, Tianjin, China
3Tianjin Medical University General Hospital, tianjin, China
4Tianjin Medical University Genernal Hospital, Tianjin, China

Aye Aye Gyi, MBBS, MMedSc, MRCP, DrMedSc, FRCP1*, Khin Thida Htut, MBBS MMedSc DrMedSc2*, Yin Nwe Han, MD3*, Mie Mie Khine, MD4,5*, Hnin Mya Thandar, MD6* and Yi Mon Thant, MBBS, MMedSc7*

1Department of Clinical Haematology, Professor and Head, North Okkalapa General and Teaching Hospital, Yangon, Myanmar
2Department of Clinicla Haematology, North Okkalapa General and Teaching Hospital, Yangon, Myanmar
3Department of Clinical Haematology, North Okkalapa General & Teaching Hospital, Yangon, MMR
4Department of Clinical Haematology, Hematology, Yangon, Yangon, Myanmar
5Department of Clinical Haematology, North Okkalapa General and Teaching Hospital, Yangon, Myanmar
6North Okkalapa General and Teaching Hospital, Yangon, Myanmar
7Clinical Haematology, North Okkalapa General and Teaching Hospital, Yangon, Myanmar

Benjamin Chin-Yee, MD1, Indermohan S. Sandhu, MBBS, MD2*, Ivan Pacheco, MD, PhD, FRCPC2,3* and Selay Lam, MD, BSc, FRCPC4

1Division of Hematology, Department of Medicine, Schulich School of Medicine and Dentistry, Western University, London Health Sciences Centre, Toronto, ON, Canada
2Grey Bruce Health Services, Owen Sound, ON, Canada
3Department of Pathology and Laboratory Medicine, Western University, London, ON, Canada
4Division of Hematology, Department of Medicine, Schulich School of Medicine and Dentistry, Western University, London Health Sciences Centre, London, ON, Canada

*signifies non-member of ASH